Stock screener

OTLK

Conviction 53HealthcareScan · Fri, Jun 26, 2026
OTLK$1.73+7.45%
ResistanceSupportVol 14Insider buy
63 bars
6
3
Vol MA14 21.09M
Mar 27Apr 15May 4May 20Jun 9Jun 26
WSB mentions · 24h changelatest -25.00%· 3 mentions
Mar 27Apr 15May 4May 20Jun 9Jun 26
Outlook Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.outlooktherapeutics.com ↗
Price1.73
Change+7.45%
Gap-4.35%
Rel volume0.61×
Avg volume21.21M
Avg $ vol25.26M
SMA 201.20
SMA 500.6569
SMA 2000.8951
Price vs 50+163.36%
Price vs 200+93.27%
MA stackmixed
50/200 cross—
Supertrendup · 1.16
RSI (14)75
MACD hist0.04
MACD cross—
Stoch %K / %D88 / 83
ADX (14)56
+DI / −DI36 / 11
RSI divergenceBearish
MACD divergence—
ATR %+10.60%
ADR %16.39%
52w high2.97
52w low0.1981
From 52w high-41.75%
Above 52w low+773.30%
New 52w highNo
SqueezeOff
Bollinger width137.62%
%B0.82
Donchian pos87.55%
Donchian high1.88
Donchian low0.6752
AVWAP (52w high)0.8464
vs AVWAP high+104.40%
AVWAP (52w low)0.6887
vs AVWAP low+151.18%
OBV trendUp
Chaikin MF (20)0.15
Today vs 20d0.61×
Avg vol (14d)21.09M
Avg vol (20d)21.21M
Avg $ vol (20d)25.26M
Market cap—
RS 3m (vs SPY)+662.24%
RS 6m (vs SPY)-19.72%
RS line new highNo
Trend template4/8
Technical rank76.0
1 week+9.49%
1 month+195.47%
3 months+723.81%
6 months-6.99%
1 year-3.89%
YTD+162.12%
P/E-3.11
P/B-6.69
P/S137.23
P/FCF-3.71
EPS-1.79
Div yield—
ROE215.30%
ROA-285.14%
Debt/Eq-33.35
Current0.54
EV/EBITDA-17.25
Gross margin4.05%
Net margin—
Rev growth—
EPS growth17.17%
Price target5.25
Target upside227.10%
Analyst ratingHold
Institutional7.62%
Ent. value1.15B
Revenue1.51M
Net income-4.45M
Gross profit-21.89K
Free cash flow-52.27M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out140.05M
Employees17
ListedFri, May 13, 2016
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeC
Conviction53 / 100
Pattern quality—
Tech rank76.0 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.41
Support0.2108
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in OTLK

All disclosures →
No recent disclosed trades by Congress in OTLK. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in OTLK · 6 buys · 4 sells

InsiderSideShares
Haddadin Yezan Munther
Director · Common Stock · 2026-06-02
Buy29K
Sukhtian Ghiath M.
Director · Warrants (right to buy) · 2026-05-28
Dispose8.57M
GMS Ventures & Investments
Director · Warrants (right to buy) · 2026-05-28
Buy8.57M
GMS Ventures & Investments
Director · Warrants (right to buy) · 2026-05-28
Dispose8.57M
GMS Ventures & Investments
Director · Warrants (right to buy) · 2026-05-28
Dispose3.46M
Sukhtian Ghiath M.
Director · Common Stock · 2026-05-28
Buy8.54M
GMS Ventures & Investments
Director · Common Stock · 2026-05-28
Buy8.54M
Sukhtian Ghiath M.
Director · Warrants (right to buy) · 2026-05-28
Buy3.46M
Sukhtian Ghiath M.
Director · Warrants (right to buy) · 2026-05-28
Buy8.57M
Sukhtian Ghiath M.
Director · Warrants (right to buy) · 2026-05-28
Dispose3.46M

SEC filings

EDGAR filings in OTLK · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.